Tissue microarray (TMA) slides containing pancreatitis and pancreas intraepithelial neoplasia were purchased from Biomax (Rockville, MD, USA; PA811, PA485,
BIC14011). Mouse tissues were formalin‐fixed, paraffin‐embedded (FFPE), and sliced. IHC was performed as described previously
12. We used the following primary antibodies: human PRDM14 (
ab187881) from Abcam Inc. (Cambridge, MA, USA) and mouse PRDM14 (#38965) from Signalway antibody (Pearland, TX, USA). The slides of mouse pancreatic tissues were also stained with hematoxylin and eosin (H&E) and
Picro‐sirius red stain kit (ScyTek Laboratories, Inc., Logan, UT, USA) for collagen staining, according to manufacturer instructions.
By light microscopy, the tissue sections of TMA were scored semiquantitatively for PRDM14 staining, as described previously
12. Labeling scores were determined by multiplying the percentage of PRDM14‐positive cells per slide (0–100%) by the dominant staining intensity (0 = negative, 1 = trace, 2 = weak, 3 = intermediate, and 4 = strong). Resulting scores ranged from 0 to 400.
In this study, we used reported data on PRDM14 staining scores in normal pancreas, PDAC, and cancer adjacent tissues using TMA
12 to compare the expression levels with that in PanIN and chronic pancreatitis.
Moriya C., Imai K, & Taniguchi H. (2018). PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer. FEBS Open Bio, 8(10), 1733-1741.